These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 28577033)

  • 1. Impact of acute hematological toxicity on treatment interruptions during cranio-spinal irradiation in medulloblastoma: a tertiary care institute experience.
    Kumar N; Miriyala R; Thakur P; Madan R; Salunke P; Yadav B; Gupta A
    J Neurooncol; 2017 Sep; 134(2):309-315. PubMed ID: 28577033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prophylactic granulocyte-colony stimulating factor (G-CSF) on acute hematological toxicity in medulloblastoma patients during craniospinal irradiation (CSI).
    Madan R; Kumar N; Gupta A; Gupta K; Salunke P; Khosla D; Yadav BS; Kapoor R
    Clin Neurol Neurosurg; 2020 Sep; 196():105975. PubMed ID: 32505868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma.
    Liu KX; Ioakeim-Ioannidou M; Susko MS; Rao AD; Yeap BY; Snijders AM; Ladra MM; Vogel J; Zaslowe-Dude C; Marcus KJ; Yock TI; Grassberger C; Braunstein SE; Haas-Kogan DA; Terezakis SA; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):726-735. PubMed ID: 33243479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late toxicity following craniospinal radiation for early-stage medulloblastoma.
    Christopherson KM; Rotondo RL; Bradley JA; Pincus DW; Wynn TT; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
    Acta Oncol; 2014 Apr; 53(4):471-80. PubMed ID: 24564687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes.
    Liu IC; Holtzman AL; Rotondo RL; Indelicato DJ; Gururangan S; Cavaliere R; Carter B; Morris CG; Tavanaiepour D; Rutenberg MS
    J Neurooncol; 2021 Jul; 153(3):467-476. PubMed ID: 34105033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protracted radiotherapy treatment duration in medulloblastoma.
    Paulino AC; Wen BC; Mayr NA; Tannous R; Loew TW; Goldman FD; Meeks SL; Ryken TC; Buatti JM
    Am J Clin Oncol; 2003 Feb; 26(1):55-9. PubMed ID: 12576926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute toxicity profile of craniospinal irradiation with intensity-modulated radiation therapy in children with medulloblastoma: A prospective analysis.
    Cox MC; Kusters JM; Gidding CE; Schieving JH; van Lindert EJ; Kaanders JH; Janssens GO
    Radiat Oncol; 2015 Nov; 10():241. PubMed ID: 26597178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.
    Kortmann RD; Kühl J; Timmermann B; Mittler U; Urban C; Budach V; Richter E; Willich N; Flentje M; Berthold F; Slavc I; Wolff J; Meisner C; Wiestler O; Sörensen N; Warmuth-Metz M; Bamberg M
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):269-79. PubMed ID: 10661332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastoma.
    Polkinghorn WR; Dunkel IJ; Souweidane MM; Khakoo Y; Lyden DC; Gilheeney SW; Becher OJ; Budnick AS; Wolden SL
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e15-20. PubMed ID: 21481547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome and toxicity using helical tomotherapy for craniospinal irradiation in pediatric medulloblastoma.
    Lopez Guerra JL; Marrone I; Jaen J; Bruna M; Sole C; Sanchez-Reyes A; Rivin E; Ortiz MJ; Calvo F; Matute R
    Clin Transl Oncol; 2014 Jan; 16(1):96-101. PubMed ID: 23632814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute toxicity and treatment interruption related to electron and photon craniospinal irradiation in pediatric patients treated at the University of Texas M. D. Anderson Cancer Center.
    Chang EL; Allen P; Wu C; Ater J; Kuttesch J; Maor MH
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1008-16. PubMed ID: 11958896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postradiation platinum-etoposide in adult medulloblastomas: retrospective analysis of hematological toxicity.
    Komlodi-Pasztor E; Munjapara V; Eberhart CG; Bazer DA; Sherief MR; Kamson DO; Ye X; Ozer BH; Holdhoff M
    CNS Oncol; 2024 Jun; 13(1):CNS107. PubMed ID: 38456492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vulnerability of white matter to insult during childhood: evidence from patients treated for medulloblastoma.
    Moxon-Emre I; Bouffet E; Taylor MD; Laperriere N; Sharpe MB; Laughlin S; Bartels U; Scantlebury N; Law N; Malkin D; Skocic J; Richard L; Mabbott DJ
    J Neurosurg Pediatr; 2016 Jul; 18(1):29-40. PubMed ID: 27015518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scoliosis in Children Treated With Photon Craniospinal Irradiation for Medulloblastoma.
    Paulino AC; Suzawa HS; Dreyer ZE; Hanania AN; Chintagumpala M; Okcu MF
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):712-717. PubMed ID: 33516438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy and overall survival in adult medulloblastoma.
    Kann BH; Lester-Coll NH; Park HS; Yeboa DN; Kelly JR; Baehring JM; Becker KP; Yu JB; Bindra RS; Roberts KB
    Neuro Oncol; 2017 Feb; 19(2):259-269. PubMed ID: 27540083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medulloblastoma: time-dose relationship based on a 30-year review.
    del Charco JO; Bolek TW; McCollough WM; Maria BL; Kedar A; Braylan RC; Mickle JP; Buatti JM; Mendenhall NP; Marcus RB
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):147-54. PubMed ID: 9747832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longterm treatment results of childhood medulloblastoma by craniospinal irradiation in supine position.
    Slampa P; Pavelka Z; Dusek L; Hynkova L; Sterba J; Ondrova B; Princ D; Novotny T; Kostakova S
    Neoplasma; 2007; 54(1):62-7. PubMed ID: 17203894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
    Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy.
    Paulino AC
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):543-7. PubMed ID: 12062595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical combinations of radiation dose and volume predict intelligence quotient and academic achievement scores after craniospinal irradiation in children with medulloblastoma.
    Merchant TE; Schreiber JE; Wu S; Lukose R; Xiong X; Gajjar A
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):554-61. PubMed ID: 25160611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.